ABSTRACT
It is well known that psoriasis is a retinoid-sensitive disease. For decades, topical as well as oral retinoids have been widely used as antipsoriatic treatments. In general, topical treatment remains the most frequently used therapy for patients with mild to moderate psoriasis, whereas systemic retinoids contribute to the therapeutic management of patients with more severe and recalcitrant types of psoriasis.
